Laboratory Medicine ›› 2025, Vol. 40 ›› Issue (11): 1047-1052.DOI: 10.3969/j.issn.1673-8640.2025.11.003
Previous Articles Next Articles
CHEN Yanqin1, FAN Lina2, YANG Dagan2(
)
Received:2025-05-22
Revised:2025-08-17
Online:2025-11-30
Published:2025-12-12
CLC Number:
CHEN Yanqin, FAN Lina, YANG Dagan. Six indirect method algorithms for establishing the reference range of serum cystatin C for adults in Hangzhou and consistency analysis[J]. Laboratory Medicine, 2025, 40(11): 1047-1052.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2025.11.003
| 项目 | 例数 | (mg·L-1) | s/ (mg·L-1) | 偏度 | 峰度 |
|---|---|---|---|---|---|
| 男性 | 14 844 | 0.85 | 0.152 | 2.604 | 35.867 |
| 19~39岁 | 5 201 | 0.80 | 0.113 | 0.711 | 2.280 |
| 40~60岁 | 7 963 | 0.85 | 0.146 | 3.640 | 70.268 |
| ≥61岁 | 1 681 | 0.98 | 0.200 | 1.446 | 4.770 |
| 女性 | 17 422 | 0.72 | 0.136 | 1.514 | 9.572 |
| 19~46岁 | 9 964 | 0.67 | 0.102 | 1.936 | 33.134 |
| ≥47岁 | 7 458 | 0.79 | 0.147 | 1.206 | 4.689 |
| 项目 | 例数 | (mg·L-1) | s/ (mg·L-1) | 偏度 | 峰度 |
|---|---|---|---|---|---|
| 男性 | 14 844 | 0.85 | 0.152 | 2.604 | 35.867 |
| 19~39岁 | 5 201 | 0.80 | 0.113 | 0.711 | 2.280 |
| 40~60岁 | 7 963 | 0.85 | 0.146 | 3.640 | 70.268 |
| ≥61岁 | 1 681 | 0.98 | 0.200 | 1.446 | 4.770 |
| 女性 | 17 422 | 0.72 | 0.136 | 1.514 | 9.572 |
| 19~46岁 | 9 964 | 0.67 | 0.102 | 1.936 | 33.134 |
| ≥47岁 | 7 458 | 0.79 | 0.147 | 1.206 | 4.689 |
| 项目 | 例数 | 非参数法/ (mg·L-1) | 参数法/ (mg·L-1) | TMC算法/(mg·L-1) | refineR算法/(mg·L-1) | Kosmic算法/(mg·L-1) | Hoffmann算法/(mg·L-1) |
|---|---|---|---|---|---|---|---|
| 男性 | 14 844 | 0.62 (0.59,0.65)~1.10 (1.06,1.13) | 0.62 (0.62,0.62)~1.10 (1.10,1.10) | 0.63 (0.62,0.63)~1.10 (1.09,1.12) | 0.62 (0.62,0.63)~1.09 (1.00,1.10) | 0.62 (0.61,0.62)~1.03 (1.02,1.03) | 0.62 (0.62,0.62)~1.10 (1.10,1.10) |
| 19~39岁 | 5 201 | 0.61 (0.59,0.64)~1.01 (0.98,1.05) | 0.61 (0.61,0.61)~1.01 (1.01,1.01) | 0.61 (0.60,0.62)~0.96 (0.94,0.97) | 0.61 (0.59,0.62)~0.99 (0.94,1.02) | 0.61 (0.61,0.61)~0.95 (0.94,0.95) | 0.61 (0.61,0.61)~1.01 (1.01,1.02) |
| 40~60岁 | 7 963 | 0.63 (0.60,0.66)~1.10 (1.06,1.13) | 0.62 (0.62,0.63)~1.10 (1.10,1.10) | 0.64 (0.63,0.64)~1.12 (1.10,1.14) | 0.63 (0.62,0.64)~1.11 (1.05,1.13) | 0.63 (0.62,0.63)~1.08 (1.07,1.08) | 0.63 (0.62,0.63)~1.10 (1.10,1.11) |
| ≥61岁 | 1 681 | 0.69 (0.64,0.72)~1.30 (1.25,1.37) | 0.68 (0.68,0.68)~1.31 (1.30,1.31) | 0.68 (0.67,0.70)~1.32 (1.26,1.38) | 0.68 (0.68,0.71)~1.26 (1.15,1.33) | 0.69 (0.68,0.71)~1.29 (1.28,1.31) | 0.68 (0.67,0.69)~1.31 (1.29,1.32) |
| 女性 | 17 422 | 0.52 (0.49,0.54)~0.96 (0.92,1.00) | 0.51 (0.51,0.51)~0.96 (0.96,0.96) | 0.51 (0.51,0.51)~0.85 (0.84,0.85) | 0.52 (0.51,0.52)~0.92 (0.84,0.95) | 0.51 (0.51,0.52)~0.91 (0.91,0.91) | 0.51 (0.51,0.52)~0.96 (0.96,0.96) |
| 19~46岁 | 9 964 | 0.50 (0.48,0.53)~0.85 (0.82,0.88) | 0.50 (0.50,0.50)~0.85 (0.85,0.85) | 0.51 (0.51,0.51)~0.86 (0.85,0.88) | 0.50 (0.50,0.51)~0.86 (0.82,0.87) | 0.51 (0.50,0.51)~0.85 (0.85,0.86) | 0.50 (0.50,0.51)~0.85 (0.85,0.85) |
| ≥47岁 | 7 458 | 0.56 (0.53,0.59)~1.05 (1.01,1.09) | 0.55 (0.55,0.56)~1.05 (1.05,1.05) | 0.56 (0.56,0.57)~1.06 (1.04,1.09) | 0.56 (0.56,0.57)~1.05 (0.97,1.06) | 0.56 (0.55,0.56)~1.05 (1.05,1.06) | 0.56 (0.55,0.56)~1.05 (1.04,1.05) |
| 项目 | 例数 | 非参数法/ (mg·L-1) | 参数法/ (mg·L-1) | TMC算法/(mg·L-1) | refineR算法/(mg·L-1) | Kosmic算法/(mg·L-1) | Hoffmann算法/(mg·L-1) |
|---|---|---|---|---|---|---|---|
| 男性 | 14 844 | 0.62 (0.59,0.65)~1.10 (1.06,1.13) | 0.62 (0.62,0.62)~1.10 (1.10,1.10) | 0.63 (0.62,0.63)~1.10 (1.09,1.12) | 0.62 (0.62,0.63)~1.09 (1.00,1.10) | 0.62 (0.61,0.62)~1.03 (1.02,1.03) | 0.62 (0.62,0.62)~1.10 (1.10,1.10) |
| 19~39岁 | 5 201 | 0.61 (0.59,0.64)~1.01 (0.98,1.05) | 0.61 (0.61,0.61)~1.01 (1.01,1.01) | 0.61 (0.60,0.62)~0.96 (0.94,0.97) | 0.61 (0.59,0.62)~0.99 (0.94,1.02) | 0.61 (0.61,0.61)~0.95 (0.94,0.95) | 0.61 (0.61,0.61)~1.01 (1.01,1.02) |
| 40~60岁 | 7 963 | 0.63 (0.60,0.66)~1.10 (1.06,1.13) | 0.62 (0.62,0.63)~1.10 (1.10,1.10) | 0.64 (0.63,0.64)~1.12 (1.10,1.14) | 0.63 (0.62,0.64)~1.11 (1.05,1.13) | 0.63 (0.62,0.63)~1.08 (1.07,1.08) | 0.63 (0.62,0.63)~1.10 (1.10,1.11) |
| ≥61岁 | 1 681 | 0.69 (0.64,0.72)~1.30 (1.25,1.37) | 0.68 (0.68,0.68)~1.31 (1.30,1.31) | 0.68 (0.67,0.70)~1.32 (1.26,1.38) | 0.68 (0.68,0.71)~1.26 (1.15,1.33) | 0.69 (0.68,0.71)~1.29 (1.28,1.31) | 0.68 (0.67,0.69)~1.31 (1.29,1.32) |
| 女性 | 17 422 | 0.52 (0.49,0.54)~0.96 (0.92,1.00) | 0.51 (0.51,0.51)~0.96 (0.96,0.96) | 0.51 (0.51,0.51)~0.85 (0.84,0.85) | 0.52 (0.51,0.52)~0.92 (0.84,0.95) | 0.51 (0.51,0.52)~0.91 (0.91,0.91) | 0.51 (0.51,0.52)~0.96 (0.96,0.96) |
| 19~46岁 | 9 964 | 0.50 (0.48,0.53)~0.85 (0.82,0.88) | 0.50 (0.50,0.50)~0.85 (0.85,0.85) | 0.51 (0.51,0.51)~0.86 (0.85,0.88) | 0.50 (0.50,0.51)~0.86 (0.82,0.87) | 0.51 (0.50,0.51)~0.85 (0.85,0.86) | 0.50 (0.50,0.51)~0.85 (0.85,0.85) |
| ≥47岁 | 7 458 | 0.56 (0.53,0.59)~1.05 (1.01,1.09) | 0.55 (0.55,0.56)~1.05 (1.05,1.05) | 0.56 (0.56,0.57)~1.06 (1.04,1.09) | 0.56 (0.56,0.57)~1.05 (0.97,1.06) | 0.56 (0.55,0.56)~1.05 (1.05,1.06) | 0.56 (0.55,0.56)~1.05 (1.04,1.05) |
| 项目 | 参数法 | TMC法 | refineR法 | Kosmic法 | Hoffmann法 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BRLL | BRUL | BRLL | BRUL | BRLL | BRUL | BRLL | BRUL | BRLL | BRUL | |||||
| 男性 | -0.006 | -0.008 | 0.058 | 0.04 | 0.016 | -0.098 | -0.025 | -0.596* | -0.008 | 0 | ||||
| 19~39岁 | 0.003 | 0.020 | -0.023 | -0.546* | 0.02 | -0.186 | -0.01 | -0.616* | 0 | 0.029 | ||||
| 40~60岁 | -0.043 | -0.001 | 0.066 | 0.144 | 0.017 | 0.067 | -0.033 | -0.175 | -0.042 | 0.008 | ||||
| ≥61岁 | -0.064 | 0.039 | -0.042 | 0.129 | -0.045 | -0.27 | 0.026 | -0.039 | -0.064 | 0.039 | ||||
| 女性 | -0.069 | 0.005 | -0.092 | -1.012* | -0.045 | -0.33 | -0.053 | -0.445* | -0.071 | 0.009 | ||||
| 19~46岁 | 0.037 | 0.009 | 0.112 | 0.167 | 0.045 | 0.078 | 0.056 | 0.045 | 0.045 | 0.011 | ||||
| ≥47岁 | -0.042 | -0.014 | 0.01 | 0.109 | -0.008 | -0.008 | -0.04 | 0.008 | -0.04 | -0.008 | ||||
| 项目 | 参数法 | TMC法 | refineR法 | Kosmic法 | Hoffmann法 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BRLL | BRUL | BRLL | BRUL | BRLL | BRUL | BRLL | BRUL | BRLL | BRUL | |||||
| 男性 | -0.006 | -0.008 | 0.058 | 0.04 | 0.016 | -0.098 | -0.025 | -0.596* | -0.008 | 0 | ||||
| 19~39岁 | 0.003 | 0.020 | -0.023 | -0.546* | 0.02 | -0.186 | -0.01 | -0.616* | 0 | 0.029 | ||||
| 40~60岁 | -0.043 | -0.001 | 0.066 | 0.144 | 0.017 | 0.067 | -0.033 | -0.175 | -0.042 | 0.008 | ||||
| ≥61岁 | -0.064 | 0.039 | -0.042 | 0.129 | -0.045 | -0.27 | 0.026 | -0.039 | -0.064 | 0.039 | ||||
| 女性 | -0.069 | 0.005 | -0.092 | -1.012* | -0.045 | -0.33 | -0.053 | -0.445* | -0.071 | 0.009 | ||||
| 19~46岁 | 0.037 | 0.009 | 0.112 | 0.167 | 0.045 | 0.078 | 0.056 | 0.045 | 0.045 | 0.011 | ||||
| ≥47岁 | -0.042 | -0.014 | 0.01 | 0.109 | -0.008 | -0.008 | -0.04 | 0.008 | -0.04 | -0.008 | ||||
| [1] |
POTTEL H, DELANAYE P, CAVALIER E. Exploring renal function assessment:creatinine,cystatin C,and estimated glomerular filtration rate focused on the European Kidney Function Consortium Equation[J]. Ann Lab Med, 2024, 44(2):135-143.
DOI URL |
| [2] | EDINGA-MELENGE B E, YAKAM A T, NANSSEU J R, et al. Reference intervals for serum cystatin C and serum creatinine in an adult sub-Saharan African population[J]. BMC Clin Pathol, 2019,19:1-9. |
| [3] | MARTINEZ-SANCHEZ L, MARQUES-GARCIA F, OZARDA Y, et al. Big data and reference intervals:rationale,current practices,harmonization and standardization prerequisites and future perspectives of indirect determination of reference intervals using routine data[J]. Adv Lab Med, 2020, 2(1):9-25. |
| [4] | Clinical and Laboratory Standards Institute. Defining,establishing,and verifying reference intervals in the clinical laboratory;approved guideline-third edition[S]. EP28-A3c,CLSI, 2010. |
| [5] |
JANSEN H I, DIRKS N F, HILLEBRAND J J, et al. Age-specific reference intervals for thyroid-stimulating hormones and free thyroxine to optimize diagnosis of thyroid disease[J]. Thyroid, 2024, 34(11):1346-1355.
DOI PMID |
| [6] |
BOHN M K, BAILEY D, BALION C, et al. Reference interval harmonization:harnessing the power of big data analytics to derive common reference intervals across populations and testing platforms[J]. Clin Chem, 2023, 69(9):991-1008.
DOI URL |
| [7] | International Organization for Standardization. Medical laboratories-requirements for quality and competence[S]. 15189,ISO, 2022. |
| [8] | 中华人民共和国国家卫生和计划生育委员会. WS/T 404.5—2015 临床常用生化检验项目参考区间第5部分:血清尿素、肌酐[S]. 北京: 中华人民共和国国家卫生和计划生育委员会,2015. |
| [9] | GHAZIZADEH H, BOHN M K, ESMAILY H, et al. Comparison of reference intervals for biochemical and hematology markers derived by direct and indirect procedures based on the Isfahan cohort study[J]. Clin Biochem, 2023,116:79-86. |
| [10] | 中华人民共和国国家卫生健康委员会.WS/T 402—2024 临床实验室定量检验项目参考区间的制定[S]. 北京: 中华人民共和国国家卫生健康委员会, 2024. |
| [11] | DAI C, WANG C, XIA F, et al. Age and gender-specific reference intervals for uric acid level in children aged 5-14 years in Southeast Zhejiang Province of China:hyperuricemia in children may need redefinition[J]. Front Pediatr, 2021,9:560720. |
| [12] | 马超超, 尹逸丛, 刘荔, 等. 影响两类间接法建立34项生物化学分析物参考区间一致性的原因探讨[J]. 中华检验医学杂志, 2023, 46(10):1083-1093. |
| [13] |
MA S, YU J, QIN X, et al. Current status and challenges in establishing reference intervals based on real-world data[J]. Crit Rev Clin Lab Sci, 2023, 60(6):427-441.
DOI URL |
| [14] | 赵海利, 杨朝菊, 李新新, 等. 河北地区健康成人血清胱抑素C参考区间调查[J]. 国际检验医学杂志, 2013, 34(18):2404-2405. |
| [15] | 林勇平, 彭淑莹, 刘忠民. 血清胱抑素C参考区间的建立及其应用[J]. 广东医学, 2012, 33(13):1954-1956. |
| [16] | NORONHA I L, SANTA-CATHARINA G P, ANDRADE L, et al. Glomerular filtration in the aging population[J]. Front Med (Lausanne), 2022,9:769329. |
| [17] |
WEI L, YE X, PEI X, et al. Reference intervals for serum cystatin C and factors influencing cystatin C levels other than renal function in the elderly[J]. PLoS One, 2014, 9(1):e86066.
DOI URL |
| [18] |
ICHIHARA K, SAITO K, ITOH Y. Sources of variation and reference intervals for serum cystatin C in a healthy Japanese adult population[J]. Clin Chem Lab Med, 2007, 45(9):1232-1236.
DOI PMID |
| [19] |
AL WAKEEL J S, MEMON N A, CHAUDHARY A R, et al. Normal reference levels of serum cystatin C in Saudi adults[J]. Saudi J Kidney Dis Transpl, 2008, 19(3):361-370.
PMID |
| [20] |
ICHIHARA K, ITOH Y, LAM C W K, et al. Sources of variation of commonly measured serum analytes in 6 Asian cities and consideration of common reference intervals[J]. Clin Chem, 2008, 54(2):356-365.
PMID |
| [21] |
HE M, KE P, CHEN W, et al. Clinical correlates and reference intervals for cystatin C in a Han population from Southeast China[J]. Clin Lab, 2017, 63(3):607-615.
DOI PMID |
| [1] | ZHANG Hui, YUAN Jingwen, ZHANG Chi. Adult reference ranges for platelet count and platelet-related parameters using fluorescence method in Wuhan [J]. Laboratory Medicine, 2025, 40(9): 892-896. |
| [2] | CAO Yue, SUN Qijuan, WANG Su, PAN Yiru, WANG Shiwen. Reference range of serum cystatin C in elders in Shanghai [J]. Laboratory Medicine, 2025, 40(8): 731-734. |
| [3] | XIONG Ying, GUO Wei. From generic to personalized:the evolution and frontiers of indirect methods for establishing reference interval [J]. Laboratory Medicine, 2025, 40(11): 1035-1041. |
| [4] | LIU Chunyan, NIU Shumin, DENG Zhaohui, LIANG Mengjie, ZHANG Xin. Establishing the reference ranges for AFP,CEA,CA72-4 and CA19-9 in Urumqi region by indirect method [J]. Laboratory Medicine, 2025, 40(11): 1053-1058. |
| [5] | PAN Yafang, ZHU Jing, SHAO Wenqi, YANG Jing, PAN Baishen, WANG Beili, GUO Wei. Establishment of reference range of serum CA50 for adults in Shanghai by indirect method [J]. Laboratory Medicine, 2025, 40(11): 1059-1063. |
| [6] | LI Li, SHI Huaying, Zaxiyangzong , Dawazhuoma , CHEN Yanmei, YANG Chunjiao, WEN Honglin. Application of indirect method in establishing reference range of adult blood lipids in Lhasa [J]. Laboratory Medicine, 2025, 40(11): 1064-1069. |
| [7] | CHEN Zhijin, WANG Yuting, ZHENG Haiyin, LIU Qingzhong. Preliminary establishment of the reference range for cytokeratin 19 fragment and analysis of related factors [J]. Laboratory Medicine, 2025, 40(11): 1070-1074. |
| [8] | LOU Zhan, PENG Tao, LIU Xingliang, YUE Binghong, LI Ran, ZHI Yongyi. Changes of serum NFL,Cys C and Lp-PLA2 levels in patients with vascular Parkinsonism and their clinical significance [J]. Laboratory Medicine, 2024, 39(9): 828-833. |
| [9] | LIU Xiaowen, SHAO Wenqi, ZHU Jing, YANG Jing, ZHANG Chunyan, PAN Baishen, WANG Beili, GUO Wei. Establishment of reference interval of serum ferritin in adults in Shanghai by indirect method [J]. Laboratory Medicine, 2024, 39(6): 524-529. |
| [10] | CHEN Haiying, GE Yafang, PAN Shun, YANG Haiou. Clinical value of inflammatory derived indicators and cystatin C in preeclampsia [J]. Laboratory Medicine, 2024, 39(6): 557-561. |
| [11] | YU Jiahui, ZHOU Lin, GUO Gang, ZHOU Jianmei. Relationship between serum homocysteine,cystatin C levels and cognitive impairment in patients with herpes simplex encephalitis [J]. Laboratory Medicine, 2024, 39(4): 393-399. |
| [12] | LIU Jingxian, CHEN Xingyue, ZHAO Jing, LIU Ying. Clinical characteristics and molecular epidemiology of Streptococcus agalactiae infection in non-pregnant adults [J]. Laboratory Medicine, 2022, 37(8): 793-797. |
| [13] | JI Wei, TIAN Guoli, ZHU Zhixing, ZHOU Zhuo, WANG Yanmin, ZHANG Xiaofen. Feasibility of indirect method to establish the cut-off value of neonatal G6PD screening in Shanghai [J]. Laboratory Medicine, 2022, 37(2): 112-116. |
| [14] | WANG Tian, ZHAO Ming, GUAN Jiahao, FU Yawen, DANG Xiaojun. Distribution characteristics of neutrophil-to-lymphocyte ratio,platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio of healthy adults in Xi’an [J]. Laboratory Medicine, 2022, 37(11): 1023-1025. |
| [15] | ZHU Qinghua, WANG Weiwei, ZOU Guanghui, DONG Zhiwu. Combined detection of serum NGAL and Cys C in the diagnosis of early nephropathy in patients with type 2 diabetes mellitus [J]. Laboratory Medicine, 2021, 36(3): 281-284. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||